Global Interventional Cardiology Surgery, Devices and Drugs Market Research and Analysis, 2015-2021

Market Insights

Global interventional cardiology surgery, devices and drugs market is expected to grow at a CAGR of 7.3% for the forecasted period of 2016-2021. The report covers three major segments of interventional cardiology market which include surgeries, devices, and drugs.  Cardiovascular diseases are the number one cause of death globally. CVDs are responsible for over 3 million diseases annually. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others.  Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China, and Japan. The market of cardiology surgery, devices and drugs are also on a rise.

One of the major factors driving the market is medical tourism. Especially in emerging markets such as India, ASEAN countries and China, the cost of surgery and treatment for cardiovascular diseases is low. In India, a heart surgery costs around 1,500 whereas in the United States it costs 5 to 10 times more than India. Hence, many Americans prefer to travel to India for their treatment.

North America is the leading market with highest market share. The market is expected to grow at a CAGR of 6.9 percent. North American marker is followed by Europe, Asia-Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR of 9.5% for the forecasted period of 2016-2021.

The report covers:

• Comprehensive research methodology of Global Interventional Cardiology Surgery, Devices and Drugs market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Global Interventional Cardiology Surgery, Devices and Drugs market.
• Insights about market determinants which are stimulating the Global Interventional Cardiology Surgery, Devices and Drugs market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players

The Market Segmentation includes

• Cardiology Devices
  • Angioplasty
  • Cardiovascular Stents
  • Cardiovascular Catheters
  • Cardiac Rhythm Management
  • Cardiovascular Assistive Devices
  • Other Cardiology Devices
• Cardiology Drugs Market By Indications
  • Antithrombotic Drugs
  • Antidyslipidemic Drugs
  • Antihypertensive Drugs
  • Anti Stroke Drugs
• Cardiology Drugs Market By Mechanism Of Action
  • Beta Blockers
  • Beta Agonists
  • Alpha Blockers
  • Alpha Agonists
  • Sodium Channel Blockers
  • Calcium Channel Blockers
  • Vasodilators
  • Renin Inhibitors
  • Angiotensin Receptor Blockers
  • Diuretics
  • Thrombolytic
• Cardiology Surgeries
  • Coronary Artery Bypass Grafting
  • Transmyocardial Laser Revascularization
  • Heart Valve Repair
  • Arrhythmia Treatment
  • Aneurysm Repair
  • Heart Transplant

Companies Profiled

• Pfizer
• Sanofi
• AstraZeneca
• Novartis
• Bristol-Myers Squibb
• Merck
• Boston Scientific Corporation
• Medtronic
• Jude Medical
• Cook Medical
• Cr Bard
• Sun Pharma
• Ge Healthcare
• Johnson And Johnson
• Takeda
• Daiichi Sankyo
• Roche
• Bayer
• Boehringer Ingelheim
• Otsuka